Renoprotective potential of dimethyl fumarate in streptozotocin induced diabetic nephropathy in Wistar rats. (June 2020)
- Record Type:
- Journal Article
- Title:
- Renoprotective potential of dimethyl fumarate in streptozotocin induced diabetic nephropathy in Wistar rats. (June 2020)
- Main Title:
- Renoprotective potential of dimethyl fumarate in streptozotocin induced diabetic nephropathy in Wistar rats
- Authors:
- Lone, Aamir
Behl, Tapan
Kumar, Arun
Makkar, Rashita
Nijhawan, Priya
Redhu, Sonika
Sharma, Himankar
Jaglan, Dharmender
Goyal, Amit - Abstract:
- Abstract: Purpose: Diabetic nephropathy (DN) is one of the most common diabetic complication in patients. The present study investigates the role of Dimethyl fumarate (DMF) in prevention of renal fibrosis in streptozotocin induced diabetic nephropathy in Wistar rats. Methods: 30 adult Wistar rats of any sex weighing 200–240 g were employed in the study. The animals were divided randomly into five groups with six animals each. DN rat model was established by i.p injection of 50 mg/kg Streptozotocin (STZ) in Wistar rats. The diseased animals were treated with three doses of DMF i.e low, medium and high viz. 20, 40 and 80 mg/kg respectively for a period of 3 months. Then, specific test were done to evaluate the activity i.e. assessment of diabetic nephropathy, lipid profile, renal hypertrophy, oxidative stress in kidney and histopathological changes in kidney tissue. Results: DMF is an FDA approved drug used in treatment of numerous sclerosis and retains antioxidant activity. The oxidative stress in diabetic models was perceived to inhibit post DMF administration. The study shown remarkably increased anti-diabetic, renoprotective, and hypolipidemic effects of DMF in STZ induced diabetic nephropathy in rats. Conclusion: STZ induced diabetic rats on treatment with DMF positively decreased the level of glucose in blood, regulated the levels of triglycerides cholesterol with enhancement of urine and serum parameters besides their antioxidant effect on kidney. Highlights: DMFAbstract: Purpose: Diabetic nephropathy (DN) is one of the most common diabetic complication in patients. The present study investigates the role of Dimethyl fumarate (DMF) in prevention of renal fibrosis in streptozotocin induced diabetic nephropathy in Wistar rats. Methods: 30 adult Wistar rats of any sex weighing 200–240 g were employed in the study. The animals were divided randomly into five groups with six animals each. DN rat model was established by i.p injection of 50 mg/kg Streptozotocin (STZ) in Wistar rats. The diseased animals were treated with three doses of DMF i.e low, medium and high viz. 20, 40 and 80 mg/kg respectively for a period of 3 months. Then, specific test were done to evaluate the activity i.e. assessment of diabetic nephropathy, lipid profile, renal hypertrophy, oxidative stress in kidney and histopathological changes in kidney tissue. Results: DMF is an FDA approved drug used in treatment of numerous sclerosis and retains antioxidant activity. The oxidative stress in diabetic models was perceived to inhibit post DMF administration. The study shown remarkably increased anti-diabetic, renoprotective, and hypolipidemic effects of DMF in STZ induced diabetic nephropathy in rats. Conclusion: STZ induced diabetic rats on treatment with DMF positively decreased the level of glucose in blood, regulated the levels of triglycerides cholesterol with enhancement of urine and serum parameters besides their antioxidant effect on kidney. Highlights: DMF attenuated blood glucose level in diabetic rats. DMF enhanced the TG and cholesterol level. DMF exerts anti-oxidant effect. … (more)
- Is Part Of:
- Obesity medicine. Volume 18(2020)
- Journal:
- Obesity medicine
- Issue:
- Volume 18(2020)
- Issue Display:
- Volume 18, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 18
- Issue:
- 2020
- Issue Sort Value:
- 2020-0018-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-06
- Subjects:
- Dimethyl fumarate -- Streptozotocin -- Diabetic nephropathy -- Oxidative stress
Obesity -- Periodicals
Obesity
Obesity
Periodicals
Periodicals
616.398005 - Journal URLs:
- https://www.clinicalkey.com/dura/browse/journalIssue/24518476 ↗
http://www.sciencedirect.com/science/journal/24518476 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.obmed.2020.100237 ↗
- Languages:
- English
- ISSNs:
- 2451-8476
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13354.xml